losartan has been researched along with Hyperkyphosis in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souza, RB | 1 |
| Kawahara, EI | 1 |
| Farinha-Arcieri, LE | 1 |
| Gyuricza, IG | 1 |
| Neofiti-Papi, B | 1 |
| Miranda-Rodrigues, M | 1 |
| Teixeira, MBCG | 1 |
| Fernandes, GR | 1 |
| Lemes, RB | 1 |
| Reinhardt, DP | 1 |
| Gouveia, CH | 1 |
| Pereira, LV | 1 |
1 other study available for losartan and Hyperkyphosis
| Article | Year |
|---|---|
Hyperkyphosis is not dependent on bone mass and quality in the mouse model of Marfan syndrome.
Topics: Animals; Female; Fibrillin-1; Kyphosis; Losartan; Male; Marfan Syndrome; Mice; Transforming Growth F | 2021 |